The Role of Epithelial–Mesenchymal Transition and IGF-1R Expression in Prediction of Gefitinib Activity as the Second-Line Treatment for Advanced Nonsmall-Cell Lung Cancer

Line Treatment ◽

Second Line ◽

The Role of Epithelial-Mesenchymal Transition and IGF-1R Expression in Prediction of Gefitinib Activity as the Second-Line Treatment for Advanced Non-Small Cell Lung Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)33918-1 ◽

2012 ◽

Vol 23 ◽

pp. ix432

Author(s):

W. Zhang ◽

B. Chen

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

Ursolic acid inhibits epithelial–mesenchymal transition by suppressing the expression of astrocyte-elevated gene-1 in human nonsmall cell lung cancer A549 cells

Anti-Cancer Drugs ◽

10.1097/cad.0b013e328360093b ◽

2013 ◽

Vol 24 (5) ◽

pp. 494-503 ◽

Cited By ~ 23

Author(s):

Kunmei Liu ◽

Le Guo ◽

Lin Miao ◽

Weiwei Bao ◽

Jue Yang ◽

...

Keyword(s):

Lung Cancer ◽

Ursolic Acid ◽

Cell Lung Cancer ◽

A549 Cells ◽

The role of topotecan in treating small cell lung cancer: second-line treatment

Lung Cancer ◽

10.1016/s0169-5002(03)90519-8 ◽

2003 ◽

Vol 41 ◽

pp. S3-S8 ◽

Cited By ~ 21

Author(s):

Joachim von Pawel

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung

The Evolving Role of Nivolumab in Non–Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology

Clinical Lung Cancer ◽

10.1016/j.cllc.2016.01.004 ◽

2016 ◽

Vol 17 (3) ◽

pp. 161-168 ◽

Cited By ~ 8

Author(s):

Cesare Gridelli ◽

Benjamin Besse ◽

Julie Renee Brahmer ◽

Lucio Crinò ◽

Enriqueta Felip ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

Treatment Algorithms ◽

International Experts

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

Annals of Oncology ◽

10.1093/annonc/mdu463 ◽

2014 ◽

Vol 25 (12) ◽

pp. 2385-2391 ◽

Cited By ~ 37

Author(s):

Q. Zhou ◽

Y. Cheng ◽

J.-J. Yang ◽

M.-F. Zhao ◽

L. Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Randomized Trial ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Line Treatment ◽

Second Line ◽

Wild Type ◽

Lung Cancer Patients ◽

Multicenter Randomized Trial

Role of the epithelial-mesenchymal transition-related circular RNA, circ-10720, in non-small-cell lung cancer

Translational Lung Cancer Research ◽

10.21037/tlcr-20-920 ◽

2021 ◽

Vol 10 (4) ◽

pp. 1804-1818

Author(s):

Jara Martín ◽

Joan Josep Castellano ◽

Ramón María Marrades ◽

Jordi Canals ◽

Nuria Viñolas ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Circular Rna ◽

Small Cell ◽

Small Cell Lung ◽

The role of GDC-0449, a hedgehog (Hh) pathway inhibitor, on epithelial–mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC) cells lines and its effect on erlotinib and cisplatin.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.10537 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 10537-10537 ◽

Cited By ~ 1

Author(s):

M. Maitah ◽

S. Ali ◽

P. LoRusso ◽

F. H. Sarkar ◽

S. M. Gadgeel

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01)

Cancer ◽

10.1002/cncr.27630 ◽

2012 ◽

Vol 118 (24) ◽

pp. 6234-6242 ◽

Cited By ~ 53

Author(s):

Jong-Mu Sun ◽

Ki Hyeong Lee ◽

Sang-we Kim ◽

Dae Ho Lee ◽

Young Joo Min ◽

...

Keyword(s):

Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Second Line ◽

Platinum Based Chemotherapy ◽

Previously Treated

TOPK mediates hypoxia-induced epithelial-mesenchymal transition and the invasion of nonsmall-cell lung cancer cells via the HIF-1α/snail axis

Biochemical and Biophysical Research Communications ◽

10.1016/j.bbrc.2020.10.068 ◽

2021 ◽

Vol 534 ◽

pp. 941-949

Author(s):

Jung-Hwan Park ◽

Minho Moon ◽

Jong-Seok Kim ◽

Sang-Muk Oh

Keyword(s):

Lung Cancer ◽

Cancer Cells ◽

Cell Lung Cancer ◽

Lung Cancer Cells ◽

miR-338-3p suppresses epithelial-mesenchymal transition and metastasis in human nonsmall cell lung cancer

Indian Journal of Cancer ◽

10.4103/0019-509x.186569 ◽

2015 ◽

Vol 52 (7) ◽

pp. 168 ◽

Cited By ~ 8

Author(s):

C Xiao-ping ◽

W Hong-yuan

Keyword(s):

Lung Cancer ◽

Cell Lung Cancer ◽